Epithelial raft cultures for investigations of virus growth, pathogenesis and efficacy of antiviral agents

Antiviral Research

Volumn 85, Issue 3, 2010, Pages 431-449

  Andrei, G ^a   Duraffour, S ^a   Van den Oord, J ^b   Snoeck, R ^a  

^a REGA INSTITUTE FOR MEDICAL RESEARCH   (Belgium)

^b UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

Adenoviruses; Herpesviruses; Organotypic epithelial raft cultures; Papillomaviruses; Parvoviruses; Poxviruses; Three dimensional cultures

Indexed keywords

2,6 DIAMINO 9 (2 PHOSPHONOMETHOXYETHYL)PURINE; 5 (2 BROMOVINYL) 2' DEOXYURIDINE; ACICLOVIR; ACYCLIC NUCLEOSIDE; ALPHA INTERFERON; ALPHA TOCOPHEROL; ALPHAN3 INTERFERON; ANTIVIRUS AGENT; BENZALKONIUM CHLORIDE; CHLORHEXIDINE; CHOLIC ACID; CIDOFOVIR; DNA; EPIGALLOCATECHIN; FOSCARNET SODIUM; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; GREEN FLUORESCENT PROTEIN; NONOXINOL 9; PARVOVIRUS VECTOR; PENCICLOVIR; PHORBOL 13 ACETATE 12 MYRISTATE; PROTEIN E6; PURINE DERIVATIVE; RECOMBINANT ALPHA2B INTERFERON; RETINOIC ACID; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA; UNINDEXED DRUG; VIRUS PROTEIN;

ADENOVIRUS; ANTINEOPLASTIC ACTIVITY; ANTIVIRAL ACTIVITY; CANCER INHIBITION; CELL CULTURE; CELL DIFFERENTIATION; CELL PROLIFERATION; DNA SYNTHESIS INHIBITION; DRUG EFFICACY; EPITHELIUM CELL; GENETIC ANALYSIS; HERPES VIRUS; HUMAN; IN VIVO CULTURE; KERATINOCYTE; LIFE CYCLE; NONHUMAN; PAPILLOMA VIRUS; PARVOVIRUS; POXVIRUS; PRIORITY JOURNAL; PROSTATIC INTRAEPITHELIAL NEOPLASIA; REGULATORY SEQUENCE; REVIEW; SQUAMOUS EPITHELIUM; TISSUE CULTURE; UTERINE CERVIX CANCER; UTERINE CERVIX CARCINOMA IN SITU; VAGINAL INTRAEPITHELIAL NEOPLASIA; VIRAL GENE DELIVERY SYSTEM; VIROGENESIS; VIRUS CELL INTERACTION; VIRUS PATHOGENESIS;

ANTIVIRAL AGENTS; CELL CULTURE TECHNIQUES; CELL DIFFERENTIATION; CELLS, CULTURED; EPITHELIAL CELLS; HUMANS; ORGAN CULTURE TECHNIQUES; VIRUSES;

HERPES; PAPILLOMAVIRIDAE; PARVOVIRUS;

EID: 76949093612     PISSN: 01663542     EISSN: 18729096     Source Type: Journal    
DOI: 10.1016/j.antiviral.2009.10.019     Document Type: Review

References (136)

1. AbdullGaffar B., Raman L.G., and Al Muala A. Cutaneous cytomegalovirus infection in a patient with acquired immunodeficiency syndrome. Int. J. Dermatol. 47 (2008) 944-946
2. Aebischer F., and McDougall J.K. Organotypic raft cultures for the in vitro evaluation of vaginal microbicidal agents. Microbicides have epithelium-specific effects when repeatedly added onto organotypic human keratinocyte cultures. Sex Transm. Dis. 24 (1997) 69-76
3. Agrawal N., You H., Liu Y., Chiriva-Internati M., Bremner J., Garg T., Grizzi F., Krishna, Prasad C., Mehta J.L., and Hermonat P.L. Generation of recombinant skin in vitro by adeno-associated virus type 2 vector transduction. Tissue Eng. 10 (2004) 1707-1715
4. Alemany R., Lai S., Lou Y.C., Jan H.Y., Fang X., and Zhang W.W. Complementary adenoviral vectors for oncolysis. Cancer Gene Ther. 6 (1999) 21-25
5. Allen M.D., Young L.S., and Dawson C.W. The Epstein-Barr virus-encoded LMP2A and LMP2B proteins promote epithelial cell spreading and motility. J. Virol. 79 (2005) 1789-1802
6. Aluigi M.G., Albini A., Carlone S., Repetto L., De Marchi R., Icardi A., Moro M., Noonan D., and Benelli R. KSHV sequences in biopsies and cultured spindle cells of epidemic, iatrogenic and Mediterranean forms of Kaposi's sarcoma. Res. Virol. 147 (1996) 267-275
7. Amon W., and Farrell P.J. Reactivation of Epstein-Barr virus from latency. Rev. Med. Virol. 15 (2005) 149-156
8. Andrei G. Three-dimensional culture models for human viral diseases and antiviral drug development. Antiviral Res. 71 (2006) 96-107
9. Andrei G., van den, Oord J., Fiten P., Opdenakker G., Wolf-Peeters C., De Clercq E., and Snoeck R. Organotypic epithelial raft cultures as a model for evaluating compounds against alphaherpesviruses. Antimicrob. Agents Chemother. 49 (2005) 4671-4680
10. Andrei G., Daelemans D., Vanstreels E., Duraffour S., Van den Oord J., De Clercq E., and Snoeck R. Identification of the type of cells responsible for transfer of herpes simplex virus (HSV) and vaccinia virus (VACV) infection to epithelial cells grown in 3D. Antiviral Res. 82 (2009) A69
11. Andrei, G., Van den Oord, J., De Clercq, E., Snoeck, R. Organotypic epithelial raft co-cultures to evaluate selectivity of anti-HPV agents. 25th International Papillomavirus Conference & Clinical Aducational Workshop, Malmö, Sweden P09:13, May 8-14, 2009b.
12. Asselineau D., and Prunieras M. Reconstruction of 'simplified' skin: control of fabrication. Br. J. Dermatol. 111 Suppl. 27 (1984) 219-222
13. Balague C., Noya F., Alemany R., Chow L.T., and Curiel D.T. Human papillomavirus E6E7-mediated adenovirus cell killing: selectivity of mutant adenovirus replication in organotypic cultures of human keratinocytes. J. Virol. 75 (2001) 7602-7611
14. Bischoff J.R., Kirn D.H., Williams A., Heise C., Horn S., Muna M., Ng L., Nye J.A., Sampson-Johannes A., Fattaey A., and McCormick F. An adenovirus mutant that replicates selectively in p53-deficient human tumor cells. Science 274 (1996) 373-376
15. Blasig C., Zietz C., Haar B., Neipel F., Esser S., Brockmeyer N.H., Tschachler E., Colombini S., Ensoli B., and Sturzl M. Monocytes in Kaposi's sarcoma lesions are productively infected by human herpesvirus 8. J. Virol. 71 (1997) 7963-7968
16. Bodily J.M., Alam S., Chen H., and Meyers C. Organotypic epithelial raft cultures and the study of the natural history of papillomavirus. In: Campo M.S. (Ed). Papillomavirus Research: From Natural History to Vaccines and Beyond (2006), Caister Academic Press, Norfolk 145-173
17. Boldogh I., Szaniszlo P., Bresnahan W.A., Flaitz C.M., Nichols M.C., and Albrecht T. Kaposi's sarcoma herpesvirus-like DNA sequences in the saliva of individuals infected with human immunodeficiency virus. Clin. Infect. Dis. 23 (1996) 406-407
18. Borza C.M., and Hutt-Fletcher L.M. Alternate replication in B cells and epithelial cells switches tropism of Epstein-Barr virus. Nat. Med. 8 (2002) 594-599
19. Bosch F.X., Lorincz A., Munoz N., Meijer C.J., and Shah K.V. The causal relation between human papillomavirus and cervical cancer. J. Clin. Pathol. 55 (2002) 244-265
20. Braun L., Durst M., Mikumo R., Crowley A., and Robinson M. Regulation of growth and gene expression in human papillomavirus-transformed keratinocytes by transforming growth factor-beta: implications for the control of papillomavirus infection. Mol. Carcinog. 6 (1992) 100-111
21. Brown J., Janniger C.K., Schwartz R.A., and Silverberg N.B. Childhood molluscum contagiosum. Int. J. Dermatol. 45 (2006) 93-99
22. Cannon J.S., Ciufo D., Hawkins A.L., Griffin C.A., Borowitz M.J., Hayward G.S., and Ambinder R.F. A new primary effusion lymphoma-derived cell line yields a highly infectious Kaposi's sarcoma herpesvirus-containing supernatant. J. Virol. 74 (2000) 10187-10193
23. Caselli E., and Di Luca D. Molecular biology and clinical associations of Roseoloviruses human herpesvirus 6 and human herpesvirus 7. New Microbiol. 30 (2007) 173-187
24. Casper C., Redman M., Huang M.L., Pauk J., Lampinen T.M., Hawes S.E., Critchlow C.W., Morrow R.A., Corey L., Kiviat N., and Wald A. HIV infection and human herpesvirus-8 oral shedding among men who have sex with men. J. Acquir. Immune. Defic. Syndr. 35 (2004) 233-238
25. Casper C., Krantz E., Selke S., Kuntz S.R., Wang J., Huang M.L., Pauk J.S., Corey L., and Wald A. Frequent and asymptomatic oropharyngeal shedding of human herpesvirus 8 among immunocompetent men. J. Infect. Dis. 195 (2007) 30-36
26. Castellsague X. Natural history and epidemiology of HPV infection and cervical cancer. Gynecol. Oncol. 110 (2008) S4-S7
27. Chow L.T., and Broker T.R. In vitro experimental systems for HPV: epithelial raft cultures for investigations of viral reproduction and pathogenesis and for genetic analyses of viral proteins and regulatory sequences. Clin. Dermatol. 15 (1997) 217-227
28. Chow L.T., Duffy A.A., Wang H.K., and Broker T.R. A highly efficient system to produce infectious human papillomavirus: elucidation of natural virus-host interactions. Cell Cycle 8 (2009) 1319-1323
29. Cohen J.I. Epstein-Barr virus infection. N. Engl. J. Med. 343 (2000) 481-492
30. Dagnino L., Pietenpol J.A., Yang E.Y., and Moses H.L. Transforming growth factor regulation of keratinocyte growth. Recent Results Cancer Res. 128 (1993) 15-29
31. Dal Pozzo F., Andrei G., Holy A., van den, Oord J., Scagliarini A., De Clercq E., and Snoeck R. Activities of acyclic nucleoside phosphonates against Orf virus in human and ovine cell monolayers and organotypic ovine raft cultures. Antimicrob. Agents Chemother. 49 (2005) 4843-4852
32. Dall K.L., Scarpini C.G., Roberts I., Winder D.M., Stanley M.A., Muralidhar B., Herdman M.T., Pett M.R., and Coleman N. Characterization of naturally occurring HPV16 integration sites isolated from cervical keratinocytes under noncompetitive conditions. Cancer Res. 68 (2008) 8249-8259
33. Dawson C.W., Rickinson A.B., and Young L.S. Epstein-Barr virus latent membrane protein inhibits human epithelial cell differentiation. Nature 344 (1990) 777-780
34. Dawson C.W., Dawson J., Jones R., Ward K., and Young L.S. Functional differences between BHRF1, the Epstein-Barr virus-encoded Bcl-2 homologue, and Bcl-2 in human epithelial cells. J. Virol. 72 (1998) 9016-9024
35. de Villiers E.M., Fauquet C., Broker T.R., Bernard H.U., and Zur H.H. Classification of papillomaviruses. Virology 324 (2004) 17-27
36. Delvenne P., Al Saleh W., Gilles C., Thiry A., and Boniver J. Inhibition of growth of normal and human papillomavirus-transformed keratinocytes in monolayer and organotypic cultures by interferon-gamma and tumor necrosis factor-alpha. Am. J. Pathol. 146 (1995) 589-598
37. DeWeese T.L., van der, Poel H., Li S., Mikhak B., Drew R., Goemann M., Hamper U., DeJong R., Detorie N., Rodriguez R., Haulk T., DeMarzo A.M., Piantadosi S., Yu D.C., Chen Y., Henderson D.R., Carducci M.A., Nelson W.G., and Simons J.W. A phase I trial of CV706, a replication-competent, PSA selective oncolytic adenovirus, for the treatment of locally recurrent prostate cancer following radiation therapy. Cancer Res. 61 (2001) 7464-7472
38. Di Giulio D.B., and Eckburg P.B. Human monkeypox: an emerging zoonosis. Lancet Infect. Dis. 4 (2004) 15-25
39. Diamond C., Brodie S.J., Krieger J.N., Huang M.L., Koelle D.M., Diem K., Muthui D., and Corey L. Human herpesvirus 8 in the prostate glands of men with Kaposi's sarcoma. J. Virol. 72 (1998) 6223-6227
40. Dictor M., Rambech E., Way D., Witte M., and Bendsoe N. Human herpesvirus 8 (Kaposi's sarcoma-associated herpesvirus) DNA in Kaposi's sarcoma lesions, AIDS Kaposi's sarcoma cell lines, endothelial Kaposi's sarcoma simulators, and the skin of immunosuppressed patients. Am. J. Pathol. 148 (1996) 2009-2016
41. Dolcetti R. B lymphocytes and Epstein-Barr virus: the lesson of post-transplant lymphoproliferative disorders. Autoimmun. Rev. 7 (2007) 96-101
42. Dollard S.C., Wilson J.L., Demeter L.M., Bonnez W., Reichman R.C., Broker T.R., and Chow L.T. Production of human papillomavirus and modulation of the infectious program in epithelial raft cultures. OFF Genes Dev. 6 (1992) 1131-1142
43. Doorbar J. The papillomavirus life cycle. J. Clin. Virol. 32 Suppl. 1 (2005) S7-15
44. Drago F., Aragone M.G., Lugani C., and Rebora A. Cytomegalovirus infection in normal and immunocompromised humans. A review. Dermatology 200 (2000) 189-195
45. Dupin N., Fisher C., Kellam P., Ariad S., Tulliez M., Franck N., van Marck E., Salmon D., Gorin I., Escande J.P., Weiss R.A., Alitalo K., and Boshoff C. Distribution of human herpesvirus-8 latently infected cells in Kaposi's sarcoma, multicentric Castleman's disease, and primary effusion lymphoma. Proc. Natl. Acad. Sci. U.S.A. 96 (1999) 4546-4551
46. Duraffour S., Snoeck R., De Vos R., van Den Oord J.J., Crance J.M., Garin D., Hruby D.E., Jordan R., De Clercq E., and Andrei G. Activity of the anti-orthopoxvirus compound ST-246 against vaccinia, cowpox and camelpox viruses in cell monolayers and organotypic raft cultures. Antivir. Ther. 12 (2007) 1205-1216
47. Duraffour S., Snoeck R., Krecmerova M., van den, Oord J., De Vos R., Holy A., Crance J.M., Garin D., De Clercq E., and Andrei G. Activities of several classes of acyclic nucleoside phosphonates against camelpox virus replication in different cell culture models. Antimicrob. Agents Chemother. 51 (2007) 4410-4419
48. Fafi-Kremer S., Morand P., Brion J.P., Pavese P., Baccard M., Germi R., Genoulaz O., Nicod S., Jolivet M., Ruigrok R.W., Stahl J.P., and Seigneurin J.M. Long-term shedding of infectious epstein-barr virus after infectious mononucleosis. J. Infect. Dis. 191 (2005) 985-989
49. Fang L., Meyers C., Budgeon L.R., and Howett M.K. Induction of productive human papillomavirus type 11 life cycle in epithelial cells grown in organotypic raft cultures. Virology 347 (2006) 28-35
50. Farwell D.G., McDougall J.K., and Coltrera M.D. Expression of Epstein-Barr virus latent membrane proteins leads to changes in keratinocyte cell adhesion. Ann. Otol. Rhinol. Laryngol. 108 (1999) 851-859
51. Fehrmann F., and Laimins L.A. Human papillomaviruses: targeting differentiating epithelial cells for malignant transformation. Oncogene 22 (2003) 5201-5207
52. Fenner F. A successful eradication campaign. Global eradication of smallpox. Rev. Infect. Dis. 4 (1982) 916-930
53. Fenner F. Smallpox: emergence, global spread, and eradication. Hist. Philos. Life Sci. 15 (1993) 397-420
54. Fishman J.A., Emery V., Freeman R., Pascual M., Rostaing L., Schlitt H.J., Sgarabotto D., Torre-Cisneros J., and Uknis M.E. Cytomegalovirus in transplantation-challenging the status quo. Clin. Transplant. 21 (2007) 149-158
55. Flores E.R., Allen-Hoffmann B.L., Lee D., Sattler C.A., and Lambert P.F. Establishment of the human papillomavirus type 16 (HPV-16) life cycle in an immortalized human foreskin keratinocyte cell line. Virology 262 (1999) 344-354
56. Frangou P., Buettner M., and Niedobitek G. Epstein-Barr virus (EBV) infection in epithelial cells in vivo: rare detection of EBV replication in tongue mucosa but not in salivary glands. J. Infect. Dis. 191 (2005) 238-242
57. Fueyo J., Gomez-Manzano C., Alemany R., Lee P.S., McDonnell T.J., Mitlianga P., Shi Y.X., Levin V.A., Yung W.K., and Kyritsis A.P. A mutant oncolytic adenovirus targeting the Rb pathway produces anti-glioma effect in vivo. Oncogene 19 (2000) 2-12
58. Garner-Hamrick P.A., Fostel J.M., Chien W.M., Banerjee N.S., Chow L.T., Broker T.R., and Fisher C. Global effects of human papillomavirus type 18 E6/E7 in an organotypic keratinocyte culture system. J. Virol. 78 (2004) 9041-9050
59. Gelb L. Varicella-zoster virus: clinical aspects. In: Roizman B., Whitley R., and Lopez C. (Eds). The Human Herpesviruses (1993), Raven Press, Ltd., New York, NY 281-308
60. Hayashi K. Role of tight junctions of polarized epithelial MDCK cells in the replication of herpes simplex virus type 1. J. Med. Virol. 47 (1995) 323-329
61. Heideman D.A., Steenbergen R.D., van der, Torre J., Scheffner M., Alemany R., Gerritsen W.R., Meijer C.J., Snijders P.J., and van Beusechem V.W. Oncolytic adenovirus expressing a p53 variant resistant to degradation by HPV E6 protein exhibits potent and selective replication in cervical cancer. Mol. Ther. 12 (2005) 1083-1090
62. Herrmann K., Frangou P., Middeldorp J., and Niedobitek G. Epstein-Barr virus replication in tongue epithelial cells. J. Gen. Virol. 83 (2002) 2995-2998
63. Hodson E.M., Jones C.A., Webster A.C., Strippoli G.F., Barclay P.G., Kable K., Vimalachandra D., and Craig J.C. Antiviral medications to prevent cytomegalovirus disease and early death in recipients of solid-organ transplants: a systematic review of randomised controlled trials. Lancet 365 (2005) 2105-2115
64. Howie H.L., Katzenellenbogen R.A., and Galloway D.A. Papillomavirus E6 proteins. Virology 384 (2009) 324-334
65. Huber M., Limat A., Wagner E., and Hohl D. Efficient in vitro transfection of human keratinocytes with an adenovirus-enhanced receptor-mediated system. J. Invest. Dermatol. 114 (2000) 661-666
66. Hukkanen V., Mikola H., Nykanen M., and Syrjanen S. Herpes simplex virus type 1 infection has two separate modes of spread in three-dimensional keratinocyte culture. J. Gen. Virol. 80 Pt 8 (1999) 2149-2155
67. Hutchin M.E., Pickles R.J., and Yarbrough W.G. Efficiency of adenovirus-mediated gene transfer to oropharyngeal epithelial cells correlates with cellular differentiation and human coxsackie and adenovirus receptor expression. Hum. Gene Ther. 11 (2000) 2365-2375
68. Jarvis M.A., and Nelson J.A. Mechanisms of human cytomegalovirus persistence and latency. Front Biosci. 7 (2002) d1575-d1582
69. Johnson A.S., Maronian N., and Vieira J. Activation of Kaposi's sarcoma-associated herpesvirus lytic gene expression during epithelial differentiation. J. Virol. 79 (2005) 13769-13777
70. Kile J.C., Fleischauer A.T., Beard B., Kuehnert M.J., Kanwal R.S., Pontones P., Messersmith H.J., Teclaw R., Karem K.L., Braden Z.H., Damon I., Khan A.S., and Fischer M. Transmission of monkeypox among persons exposed to infected prairie dogs in Indiana in 2003. Arch. Pediatr. Adolesc. Med. 159 (2005) 1022-1025
71. Koelle D.M., Huang M.L., Chandran B., Vieira J., Piepkorn M., and Corey L. Frequent detection of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) DNA in saliva of human immunodeficiency virus-infected men: clinical and immunologic correlates. J. Infect. Dis. 176 (1997) 94-102
72. Komaroff A.L., Jacobson S., Ablashi D.V., and Yamanishi K. Highlights from 5th international conference on HHV-6 and -7. Herpes 13 (2006) 81-82
73. Kondo K., Nozaki H., Shimada K., and Yamanishi K. Detection of a gene cluster that is dispensable for human herpesvirus 6 replication and latency. J. Virol. 77 (2003) 10719-10724
74. Lagunoff M., Bechtel J., Venetsanakos E., Roy A.M., Abbey N., Herndier B., McMahon M., and Ganem D. De novo infection and serial transmission of Kaposi's sarcoma-associated herpesvirus in cultured endothelial cells. J. Virol. 76 (2002) 2440-2448
75. Lambert P.F., Ozbun M.A., Collins A., Holmgren S., Lee D., and Nakahara T. Using an immortalized cell line to study the HPV life cycle in organotypic "raft" cultures. Methods Mol. Med. 119 (2005) 141-155
76. Lebeau I., Andrei G., Dal Pozzo F., Beadle J.R., Hostetler K.Y., De Clercq E., van den Oord J., and Snoeck R. Activities of alkoxyalkyl esters of cidofovir (CDV), cyclic CDV, and (S)-9-(3-hydroxy-2-phosphonylmethoxypropyl)adenine against orthopoxviruses in cell monolayers and in organotypic cultures. Antimicrob. Agents Chemother. 50 (2006) 2525-2529
77. Lee J.Y. Cytomegalovirus infection involving the skin in immunocompromised hosts. A clinicopathologic study. Am. J. Clin. Pathol. 92 (1989) 96-100
78. Lesher Jr. J.L. Cytomegalovirus infections and the skin. J. Am. Acad. Dermatol. 18 (1988) 1333-1338
79. Longworth M.S., and Laimins L.A. Pathogenesis of human papillomaviruses in differentiating epithelia. Microbiol. Mol. Biol. Rev. 68 (2004) 362-372
80. Lu C., Zeng Y., Huang Z., Huang L., Qian C., Tang G., and Qin D. Human herpesvirus 6 activates lytic cycle replication of Kaposi's sarcoma-associated herpesvirus. Am. J. Pathol. 166 (2005) 173-183
81. Mason B., Ghanee N., Haigh W.G., Lee S.P., and Oda D. Effect of vitamins A, C and E on normal and HPV-immortalized human oral epithelial cells in culture. Anticancer Res. 19 (1999) 5469-5474
82. Massad L.S., Turyk M.E., Bitterman P., and Wilbanks G.D. Interferon-alpha and all-trans-retinoic acid reversibly inhibit the in vitro proliferation of cell lines derived from cervical cancers. Gynecol. Oncol. 60 (1996) 428-434
83. McGuigan C., Pathirana R.N., Migliore M., Adak R., Luoni G., Jones A.T., Diez-Torrubia A., Camarasa M.J., Velazquez S., Henson G., Verbeken E., Sienaert R., Naesens L., Snoeck R., Andrei G., and Balzarini J. Preclinical development of bicyclic nucleoside analogues as potent and selective inhibitors of varicella zoster virus. J. Antimicrob. Chemother. 60 (2007) 1316-1330
84. McLaughlin-Drubin M.E., and Munger K. The human papillomavirus E7 oncoprotein. Virology 384 (2009) 335-344
85. McLaughlin-Drubin M.E., Wilson S., Mullikin B., Suzich J., and Meyers C. Human papillomavirus type 45 propagation, infection, and neutralization. Virology 312 (2003) 1-7
86. McLaughlin-Drubin M.E., Bromberg-White J.L., and Meyers C. The role of the human papillomavirus type 18 E7 oncoprotein during the complete viral life cycle. Virology 338 (2005) 61-68
87. Meyers C., Frattini M.G., Hudson J.B., and Laimins L.A. Biosynthesis of human papillomavirus from a continuous cell line upon epithelial differentiation. Science 257 (1992) 971-973
88. Meyers C., Mayer T.J., and Ozbun M.A. Synthesis of infectious human papillomavirus type 18 in differentiating epithelium transfected with viral DNA. J. Virol. 71 (1997) 7381-7386
89. Meyers C., Mane M., Kokorina N., Alam S., and Hermonat P.L. Ubiquitous human adeno-associated virus type 2 autonomously replicates in differentiating keratinocytes of a normal skin model. Virology 272 (2000) 338-346
90. Meyers C., Andreansky S.S., and Courtney R.J. Replication and interaction of herpes simplex virus and human papillomavirus in differentiating host epithelial tissue. Virology 315 (2003) 43-55
91. Mori Y. Recent topics related to human herpesvirus 6 cell tropism. Cell Microbiol. 11 (2009) 1001-1006
92. Munger K., Baldwin A., Edwards K.M., Hayakawa H., Nguyen C.L., Owens M., Grace M., and Huh K. Mechanisms of human papillomavirus-induced oncogenesis. J. Virol. 78 (2004) 11451-11460
93. Nahmias A.J., Lee F.K., and Beckman-Nahmias S. Sero-epidemiological and -sociological patterns of herpes simplex virus infection in the world. Scand. J. Infect. Dis. Suppl. 69 (1990) 19-36
94. Nassetta L., Kimberlin D., and Whitley R. Treatment of congenital cytomegalovirus infection: implications for future therapeutic strategies. J. Antimicrob. Chemother. 63 (2009) 862-867
95. Nemunaitis J., Ganly I., Khuri F., Arseneau J., Kuhn J., McCarty T., Landers S., Maples P., Romel L., Randlev B., Reid T., Kaye S., and Kirn D. Selective replication and oncolysis in p53 mutant tumors with ONYX-015, an E1B-55 kD gene-deleted adenovirus, in patients with advanced head and neck cancer: a phase II trial. Cancer Res. 60 (2000) 6359-6366
96. Noya F., Balague C., Banerjee N.S., Curiel D.T., Broker T.R., and Chow L.T. Activation of adenovirus early promoters and lytic phase in differentiated strata of organotypic cultures of human keratinocytes. J. Virol. 77 (2003) 6533-6540
97. Ozbun M.A., and Meyers C. Characterization of late gene transcripts expressed during vegetative replication of human papillomavirus type 31b. J. Virol. 71 (1997) 5161-5172
98. Parkin D.M., and Bray F. Chapter 2: the burden of HPV-related cancers. Vaccine 24 Suppl. 3 (2006) S3-11-S3-25
99. Pattle S.B., and Farrell P.J. The role of Epstein-Barr virus in cancer. Exp. Opin. Biol. Ther. 6 (2006) 1193-1205
100. Qin D., Zeng Y., Qian C., Huang Z., Lv Z., Cheng L., Yao S., Tang Q., Chen X., and Lu C. Induction of lytic cycle replication of Kaposi's sarcoma-associated herpesvirus by herpes simplex virus type 1: involvement of IL-10 and IL-4. Cell Microbiol. 10 (2008) 713-728
101. Rafailidis P.I., Mourtzoukou E.G., Varbobitis I.C., and Falagas M.E. Severe cytomegalovirus infection in apparently immunocompetent patients: a systematic review. Virol. J. 5 (2008) 47
102. Reeves M., and Sinclair J. Aspects of human cytomegalovirus latency and reactivation. Curr. Top. Microbiol. Immunol. 325 (2008) 297-313
103. Renard I., Mezzanzanica D., Canevari S., Ferrini S., Boniver J., Delvenne P., and Jacobs N. Anti-CD3/anti-epidermal growth factor receptor-bispecific antibody retargeting of lymphocytes against human neoplastic keratinocytes in an autologous organotypic culture model. Am. J. Pathol. 160 (2002) 113-122
104. Rodriguez R., Schuur E.R., Lim H.Y., Henderson G.A., Simons J.W., and Henderson D.R. Prostate attenuated replication competent adenovirus (ARCA) CN706: a selective cytotoxic for prostate-specific antigen-positive prostate cancer cells. Cancer Res. 57 (1997) 2559-2563
105. Sarma D., Yang X., Jin G., Shindoh M., Pater M.M., and Pater A. Resistance to retinoic acid and altered cytokeratin expression of human papillomavirus type 16-immortalized endocervical cells after tumorigenesis. Int. J. Cancer 65 (1996) 345-350
106. Scholle F., Bendt K.M., and Raab-Traub N. Epstein-Barr virus LMP2A transforms epithelial cells, inhibits cell differentiation, and activates Akt. J. Virol. 74 (2000) 10681-10689
107. Sen E., McLaughlin-Drubin M., and Meyers C. Efficacy of two commercial preparations of interferon-alpha on human papillomavirus replication. Anticancer Res. 25 (2005) 1091-1100
108. Shindoh M., Sun Q., Pater A., and Pater M.M. Prevention of carcinoma in situ of human papillomavirus type 16-immortalized human endocervical cells by retinoic acid in organotypic raft culture. Obstet. Gynecol. 85 (1995) 721-728
109. Sinclair J. Human cytomegalovirus: latency and reactivation in the myeloid lineage. J. Clin. Virol. 41 (2008) 180-185
110. Smith J.S., and Robinson N.J. Age-specific prevalence of infection with herpes simplex virus types 2 and 1: a global review. J. Infect. Dis. 186 Suppl. 1 (2002) S3-28
111. Snoeck R., Holy A., Dewolf-Peeters C., van den, Oord J., De Clercq E., and Andrei G. Antivaccinia activities of acyclic nucleoside phosphonate derivatives in epithelial cells and organotypic cultures. Antimicrob. Agents Chemother. 46 (2002) 3356-3361
112. Sporn M.B., and Roberts A.B. TGF-beta: problems and prospects. Cell Regul. 1 (1990) 875-882
113. Stanley M. Immune responses to human papillomavirus. Vaccine 24 Suppl. 1 (2006) S16-S22
114. Sturzl M., Blasig C., Schreier A., Neipel F., Hohenadl C., Cornali E., Ascherl G., Esser S., Brockmeyer N.H., Ekman M., Kaaya E.E., Tschachler E., and Biberfeld P. Expression of HHV-8 latency-associated T0.7 RNA in spindle cells and endothelial cells of AIDS-associated, classical and African Kaposi's sarcoma. Int. J. Cancer 72 (1997) 68-71
115. Syrjanen S., Mikola H., Nykanen M., and Hukkanen V. In vitro establishment of lytic and nonproductive infection by herpes simplex virus type 1 in three-dimensional keratinocyte culture. J. Virol. 70 (1996) 6524-6528
116. Takada K. Role of Epstein-Barr virus in Burkitt's lymphoma. Curr. Top. Microbiol. Immunol. 258 (2001) 141-151
117. Thompson M.P., and Kurzrock R. Epstein-Barr virus and cancer. Clin. Cancer Res. 10 (2004) 803-821
118. Thorley-Lawson D.A., and Gross A. Persistence of the Epstein-Barr virus and the origins of associated lymphomas. N. Engl. J. Med. 350 (2004) 1328-1337
119. Tran T., Druce J.D., Catton M.C., Kelly H., and Birch C.J. Changing epidemiology of genital herpes simplex virus infection in Melbourne, Australia, between 1980 and 2003. Sex Transm. Infect. 80 (2004) 277-279
120. Tyring S.K. Molluscum contagiosum: the importance of early diagnosis and treatment. Am. J. Obstet. Gynecol. 189 (2003) S12-S16
121. Varthakavi V., Smith R.M., Deng H., Sun R., and Spearman P. Human immunodeficiency virus type-1 activates lytic cycle replication of Kaposi's sarcoma-associated herpesvirus through induction of KSHV Rta. Virology 297 (2002) 270-280
122. Vieira J., O'Hearn P., Kimball L., Chandran B., and Corey L. Activation of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) lytic replication by human cytomegalovirus. J. Virol. 75 (2001) 1378-1386
123. Visalli R.J., Courtney R.J., and Meyers C. Infection and replication of herpes simplex virus type 1 in an organotypic epithelial culture system. Virology 230 (1997) 236-243
124. Vorou R.M., Papavassiliou V.G., and Pierroutsakos I.N. Cowpox virus infection: an emerging health threat. Curr. Opin. Infect. Dis. 21 (2008) 153-156
125. Walling D.M., Flaitz C.M., Nichols C.M., Hudnall S.D., and Adler-Storthz K. Persistent productive Epstein-Barr virus replication in normal epithelial cells in vivo. J. Infect. Dis. 184 (2001) 1499-1507
126. Wang H.K., Duffy A.A., Broker T.R., and Chow L.T. Robust production and passaging of infectious HPV in squamous epithelium of primary human keratinocytes. Genes Dev. 23 (2009) 181-194
127. Wentzensen N., Vinokurova S., von Knebel, and Doeberitz M. Systematic review of genomic integration sites of human papillomavirus genomes in epithelial dysplasia and invasive cancer of the female lower genital tract. Cancer Res. 64 (2004) 3878-3884
128. Whitley R. The epidemiology and clinical manifestations of herpes simplex virus infections. In: Roizman B., Whitley R., and Lopez C. (Eds). The Human Herpesviruses (1993), Raven Press, Ltd., New York, NY 69-105
129. Wilson R., Fehrmann F., and Laimins L.A. Role of the E1-E4 protein in the differentiation-dependent life cycle of human papillomavirus type 31. J. Virol. 79 (2005) 6732-6740
130. Woodworth C.D., Notario V., and DiPaolo J.A. Transforming growth factors beta 1 and 2 transcriptionally regulate human papillomavirus (HPV) type 16 early gene expression in HPV-immortalized human genital epithelial cells. J. Virol. 64 (1990) 4767-4775
131. Yokoyama M., Nakao Y., Iwasaka T., Pater A., and Sugimori H. Retinoic acid and interferon-alpha effects on cell growth and differentiation in cervical carcinoma cell lines. Obstet. Gynecol. 98 (2001) 332-340
132. Yokoyama T., Du J., Kawamoto Y., Suzuki H., and Nakashima I. Inhibition of Fas-mediated apoptotic cell death of murine T lymphocytes in a mouse model of immunosenescence in linkage to deterioration in cell membrane raft function. Immunology 112 (2004) 64-71
133. Yoshikawa T. Human herpesvirus-6 and -7 infections in transplantation. Pediatr. Transplant. 7 (2003) 11-17
134. Yu D.C., Sakamoto G.T., and Henderson D.R. Identification of the transcriptional regulatory sequences of human kallikrein 2 and their use in the construction of calydon virus 764, an attenuated replication competent adenovirus for prostate cancer therapy. Cancer Res. 59 (1999) 1498-1504
135. Zeng Y., Zhang X., Huang Z., Cheng L., Yao S., Qin D., Chen X., Tang Q., Lv Z., Zhang L., and Lu C. Intracellular Tat of human immunodeficiency virus type 1 activates lytic cycle replication of Kaposi's sarcoma-associated herpesvirus: role of JAK/STAT signaling. J. Virol. 81 (2007) 2401-2417
136. Zerr D.M. Human herpesvirus 6: a clinical update. Herpes 13 (2006) 20-24